Synergy CHC Corp.
SNYR- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001562733
No open-market purchases or sales by Synergy CHC Corp. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $133.1K in total; no superinvestor holds it.
Other share classesSNYRQ
13F holders, Q1 2025
Institutional positions in Synergy CHC Corp. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- +1 vs. Q4 2024
- Shares held
- 905.4K
- +2.59K (+0.3%) vs. Q4 2024
- Total value
- $2.13M
- −$1.88M (−46.9%) vs. Q4 2024
- New holders
- 2
- 3 more added
- Sold out
- 1
- 2 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNYR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $133.1K |
| Q1 2026 | 13 | $2.17M |
| Q4 2025 | 12 | $2.41M |
| Q3 2025 | 11 | $4.00M |
| Q2 2025 | 6 | $1.22M |
| Q1 2025 | 9 | $2.13M |
| Q4 2024 | 9 | $4.05M |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Synergy CHC Corp.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sanders Morris Harris LLC | 391,485 | $920.0K | 0.14% | +12,930+3.4% | Added |
| Pacific Ridge Capital Partners, LLC | 378,767 | $890.1K | 0.23% | −13,899−3.5% | Reduced |
| Gratia Capital, LLC | 105,944 | $249.0K | 0.28% | 00.0% | Unchanged |
| Vanguard Group Inc | 22,134 | $53.3K | 0.00% | +22,134 | New |
| UBS Group AG | 3,481 | $8.18K | 0.00% | +1,875+116.7% | Added |
| BlackRock, Inc. | 1,766 | $4.15K | 0.00% | −36−2.0% | Reduced |
| Tower Research Capital LLC (TRC) | 1,724 | $4.05K | 0.00% | +1,500+669.6% | Added |
| Barclays PLC | 88 | $207 | 0.00% | +88 | New |
| Bank of America Corp | 9 | $21 | 0.00% | 00.0% | Unchanged |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |